Snowball logo
logo
BHVN

Biohaven Pharmaceutical Holding Co Ltd

BHVN β€’ NYSE
$14.38+$0.70Β  (5.12%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
462.5-----
COGS
1.3931.3863.3693.9234.139999-
Gross Profit
370.8(1.386)(3.369)(3.923)(4.139999)-
Operating Expenses & Income
Operating Income
(218.9)(567.9)(436.1)(885.1)(745.4)(567.4)
Total Operating Expenses
218.9567.9436.1885.1741.2565.4
R&D Expenses
181.5437.1373.3795.9635.1467.8
Selling General & Admin Expenses
37.41130.962.7789.24106.299.69
Earnings from Continuing Operations
Interest Expense
(41.55)(1.386)----
Interest Income
------
Income Tax Expense
1.3660.438(1.383)0.7351.4421.235
Net Income
Net Income
(213.8)(570.3)(408.2)(846.4)(738.8)(586.8)
Supplemental
EBIT
(212.4)(569.8)(409.6)(845.7)(737.4)-
EBITDA
(211)(568.5)(402.6)(837.8)(727.5)(567.5)
In millions of USD, except % and values per 1 share